Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Cytochrome P450 3A4 Inducers [MoA]: Side Effects & Safety Data for 21 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Cytochrome P450 3A4 Inducers [MoA] includes 21 drugs with a combined 195,439 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

21
Drugs in Class
195,439
Combined Reports

All Cytochrome P450 3A4 Inducers [MoA] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
ENZALUTAMIDE Xtandi 49,270 9,676 9,282 19.6%
TOPIRAMATE Topiramate 28,609 3,527 7,098 12.3%
OSIMERTINIB TAGRISSO 27,750 12,456 5,277 44.9%
CARBAMAZEPINE Carbamazepine 24,577 2,156 9,608 8.8%
DABRAFENIB Tafinlar 19,305 4,165 5,325 21.6%
DEFERASIROX Deferasirox 11,322 2,661 4,008 23.5%
CLOBAZAM Clobazam 10,596 725 3,312 6.8%
CENOBAMATE Xcopri 5,643 125 1,012 2.2%
APREPITANT CINVANTI 5,620 1,195 2,917 21.3%
ESLICARBAZEPINE Eslicarbazepine Acetate 3,127 97 750 3.1%
IVOSIDENIB TIBSOVO 1,695 121 505 7.1%
OMAVELOXOLONE SKYCLARYS 1,249 54 304 4.3%
ERDAFITINIB BALVERSA 1,106 315 226 28.5%
BELZUTIFAN WELIREG 1,021 82 550 8.0%
MITOTANE Lysodren 1,011 88 245 8.7%
FOSAPREPITANT DIMEGLUMINE Fosaprepitant 888 118 364 13.3%
ORITAVANCIN Orbactiv 884 29 157 3.3%
PITOLISANT Wakix 843 7 70 0.8%
FOSAMPRENAVIR Fosamprenavir Calcium 460 31 91 6.7%
ORITAVANCIN DIPHOSPHATE Kimyrsa 276 4 27 1.4%
REPOTRECTINIB Augtyro 187 27 48 14.4%

Common Side Effects in Cytochrome P450 3A4 Inducers [MoA] Drugs

Side EffectReportsDeaths
Death 22,766 22,730
Fatigue 16,463 1,759
Drug ineffective 16,437 1,622
Off label use 10,803 1,812
Nausea 9,867 1,330
Malignant neoplasm progression 9,558 2,869
Seizure 9,055 311
Diarrhoea 8,348 1,391
Pyrexia 7,763 1,158
Dizziness 7,587 1,007
View detailed side effects for this class → Compare drugs in this class →